Reversal of dyskinesias in an animal model of Parkinson's disease by continuous l -DOPA delivery using rAAV vectors

ISSN： 1460-2156

Source： Brain, Vol.128, Iss.3, 2005-03, pp. : 559-569

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Implanted reuptake-deficient or wild-type dopaminergic neurons improve ON l-dopa dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease

By Vinuela A.

Brain, Vol. 131, Iss. 12, 2008-12 ,pp. : 3361-3379

Oxford University Press

Access to resources Recommend Favorite

Progress in Direct Striatal Delivery of l-Dopa via Gene Therapy for Treatment of Parkinson's Disease Using Recombinant Adeno-Associated Viral Vectors

By Mandel R.J. Rendahl K.G. Snyder R.O. Leff S.E.

Experimental Neurology, Vol. 159, Iss. 1, 1999-09 ,pp. : 47-64

Elsevier

Access to resources Recommend Favorite

Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinsons disease

By Bjrklund Tomas

Brain, Vol. 133, Iss. 2, 2010-02 ,pp. : 496-511

Oxford University Press

Access to resources Recommend Favorite

Lentiviral Vectors as a Gene Delivery System in the Mouse Midbrain: Cellular and Behavioral Improvements in a 6-OHDA Model of Parkinson's Disease Using GDNF

By Bensadoun J.-C. Deglon N. Tseng J.L. Ridet J.-L. Zurn A.D. Aebischer P.

Experimental Neurology, Vol. 164, Iss. 1, 2000-07 ,pp. : 15-24

Elsevier

Access to resources Recommend Favorite

Effect of Acute l-Dopa Pretreatment on Apomorphine-Induced Rotational Behavior in a Rat Model of Parkinson's Disease

By Mandel R.J.

Experimental Neurology, Vol. 161, Iss. 1, 2000-01 ,pp. : 212-219

Elsevier

Access to resources Recommend Favorite